Document Type : Original Research
Authors
1 MSc, Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2 PhD, Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3 MD, Department of Radiotherapy & Oncology, Omid Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
4 MD, Department of General Surgery, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
Background: Breast cancer is the most common cancer among women. Considering the fact that a high dose is delivered in a single fraction of IORT, the evaluation of the dose at sensitive organs like thyroid is necessary.
Objective: The current study has aimed to evaluate the received dose to thyroid lobes in the breast IORT technique.
Material and Methods: A total of 49 women with breast cancer undergoing IORT were enrolled in this cross-sectional study with census sampling. Immediately after tumor resection, a single dose of 20 Gray at the applicator surface was delivered using 50KV X-ray by an Intrabeam machine. The thyroid dose was detected using thermoluminescent detectors (TLD) 100 at the mid-thyroid line, left and right lobes.
Results: The dose at the right and left lobes of the thyroid gland as well as the mid-thyroid line was found to be 40.18±35.44 mGy, 35.50±27.32 mGy, and 40.61±32.47 mGy, respectively. The right lobe received a significantly higher absorbed dose compared to the left lobe when the right breast was under IORT treatment. The same trend was seen with the left lobe and left breast under IORT treatment (P=0.0001 and P=0.018, respectively). The applicator size showed non-significant effects on the absorbed dose at the thyroid gland. Also, the applicator depth had a non-significant inverse effect on thyroid dose.
Conclusion: According to our findings, the absorbed dose at each thyroid lobe depends on the under-treatment side as well as the applicator size and depth (applicator upper surface distance from the skin).
Keywords
- Brady LW, Perez CA, Wazer DE. Perez & Brady’s principles and practice of radiation oncology. Lippincott Williams & Wilkins; 2013.
- Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology. 2005;23(9):1934-40.
- Wood WC, Shipley WU, Gunderson LL, Cohen AM, Nardi GL. Intraoperative irradiation for unresectable pancreatic carcinoma. Cancer. 1982;49(6):1272-5. doi: 10.1002/1097-0142(19820315)49:6
- Kraus-Tiefenbacher U, Scheda A, Steil V, Hermann B, Kehrer T, Bauer L, Melchert F, Wenz F. Intraoperative radiotherapy (IORT) for breast cancer using the intrabeam™ system. Tumori Journal. 2005;91(4):339-45. doi: 10.1177/030089160509100411.
- Kraus-Tiefenbacher U, Bauer L, Scheda A, Schoeber C, Schaefer J, Steil V, Wenz F. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer. 2007;7(1):178. doi: 10.1186/1471-2407-7-178.
- Gatzemeier W, Orecchia R, Gatti G, Intra M, Veronesi U. Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand. Strahlenther Onkol. 2001;177(7):330-7. doi: 10.1007/pl00002415. PubMed PMID: 11505618.
- Richardson DB. Exposure to Lonizing Radiation in Adulthood and Thyroid Cancer Incidence. Epidemiology. 2009;20(2):181-7.
- Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiation Research. 1992;131(1):98-111. doi: 10.2307/3578322.
- Schneider AB, Ron EL, Lubin J, Stovall M, Gierlowski TC. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. The Journal of Clinical Endocrinology & Metabolism. 1993;77(2):362-9. doi: 10.1210/jcem.77.2.8345040.
- International Atomic Energy Agency . Absorbed Dose Determination in External Beam Radiotherapy. Technical Report Series No. 398; Vienna: IAEA; 2000.
- Fogg P, Das KR, Kron T, Fox C, Chua B, Hagekyriakou J. Thermoluminescence dosimetry for skin dose assessment during intraoperative radiotherapy for early breast cancer. Australasian Physical & Engineering Sciences in Medicine. 2010;33(2):211-4. doi: 10.1007/s13246-010-0019-3.
- Kron T, Butson M, Hunt F, Denham J. TLD extrapolation for skin dose determination in vivo. Radiotherapy and oncology. 1996;41(2):119-23
)